Back to News
Market Impact: 0.25
Drug Benefits Firm Rightway Eyes Eventual IPO After New Funding
Source: Bloomberg
IPOs & SPACsHealthcare & BiotechAntitrust & Competition
Rightway, a pharmacy benefit manager serving about 3 million people, is considering an IPO in the coming years. The potential listing would support its effort to gain share in the US PBM market, which is dominated by large healthcare conglomerates.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
- CoreWeave confronts 'doom cycle' narrative as neocloud credit risk overshadows growth
- Bon Secours affiliate sweetens bid for Surgery Partners to up to $6 billion
- CorMedix stock gains as Heron deal adds four products
- Rezolute at Guggenheim: FDA progress lifts rare-disease hopes
- Hims & Hers earnings up next: Can GLP-1 boom drive profit?